Infleqtion (NYSE:INFQ) Upgraded at Wall Street Zen

Infleqtion (NYSE:INFQ) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

INFQ has been the topic of several other reports. BTIG Research assumed coverage on shares of Infleqtion in a report on Friday, April 10th. They issued a “buy” rating and a $22.00 price objective on the stock. UBS Group assumed coverage on shares of Infleqtion in a research note on Wednesday, April 29th. They issued a “buy” rating on the stock. Citigroup assumed coverage on shares of Infleqtion in a research note on Tuesday, April 14th. They issued a “buy” rating and a $20.00 price target on the stock. Finally, Weiss Ratings assumed coverage on shares of Infleqtion in a research note on Wednesday. They issued a “sell (d)” rating on the stock. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

Infleqtion Price Performance

NYSE:INFQ opened at $16.15 on Friday. Infleqtion has a 1-year low of $8.52 and a 1-year high of $27.50. The firm has a market capitalization of $3.52 billion and a P/E ratio of -179.39.

Infleqtion (NYSE:INFQ) last posted its quarterly earnings results on Tuesday, March 31st. The quantum tech company reported ($0.83) earnings per share (EPS) for the quarter.

Insider Buying and Selling at Infleqtion

In related news, CRO Paul Lipman sold 100,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $15.83, for a total value of $1,583,000.00. Following the completion of the transaction, the executive owned 100,000 shares in the company, valued at $1,583,000. This trade represents a 50.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Matthew John Kinsella sold 545,824 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $17.19, for a total transaction of $9,382,714.56. Following the completion of the transaction, the chief executive officer owned 545,824 shares of the company’s stock, valued at approximately $9,382,714.56. This trade represents a 50.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 27,991,988 shares of company stock worth $440,130,118 in the last 90 days.

Trending Headlines about Infleqtion

Here are the key news stories impacting Infleqtion this week:

• Positive Sentiment: Infleqtion announced a major expansion of its UK quantum operations with a new Oxford Innovation Centre and manufacturing hub, which supports its long-term growth and capacity story. Article Title
• Positive Sentiment: Market commentary also highlighted Infleqtion’s plan to expand production capacity by threefold, which investors are reading as a signal of expected demand growth. Article Title
• Positive Sentiment: Reports that the U.S. government may invest up to $100 million in Infleqtion and other quantum names have boosted sentiment around the sector and validated the company’s strategic importance. Article Title
• Neutral Sentiment: Wall Street remains generally constructive, with several Buy ratings and an average price target near $21, though the stock remains volatile. Article Title
• Negative Sentiment: Large insider sales are a key overhang, including Director David B. Singer’s multimillion-share disposals and CEO Matthew John Kinsella’s repeated sales, which may be pressuring the stock. Article Title
• Negative Sentiment: More recent filings show CRO Paul Lipman sold 100,000 shares, adding to concerns that insiders are trimming exposure after the recent rally. Article Title

Infleqtion Company Profile

We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.